- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00806377
Deactivation of Implantable Cardioverter Defibrillator During Non-thoracic Surgical Procedures (Dinosur)
The purpose of this study is:
- To document the incidence of electromagnetic oversensing of ICDs during non-thoracic surgery.
- To identify any non-thoracic procedure with a higher incidence of generating electromagnetic oversensing.
- To document the ability of dual chamber ICDs to discriminate electromagnetic oversensing.
Study Overview
Status
Conditions
Detailed Description
Electrocautery devices used during surgery generate a high electromagnetic field with a frequency that may result in ICD oversensing. Oversensing may in turn result in false detection of a ventricular arrhythmia and for the ICD to discharge. Because of this possibility, patients frequently have their ICDs inactivated prior to the procedure.
Although oversensing appears to be highly unlikely in clinical practice, vast resources are utilized in the process of deactivating and reactivating ICDs for surgeries. In addition, there are reports of deaths from failure to reactivate ICDs following elective surgery.
In this study we intend to document the incidence of oversensing, identify procedures with a higher likelihood of oversensing and evaluate the ability of dual chamber ICDs to discriminate electromagnetic oversensing.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55407
- Abbott Northwestern Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with Medtronic or Boston Scientific single and dual chamber ICDs
Exclusion Criteria:
- Non-thoracic ICD generator placement (abdominal)
- Pregnant
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Electromagnetic oversensing will be reported as a percentage of the total enrolled patients
Time Frame: Assessed at time of procedure
|
Assessed at time of procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Non-thoracic procedures with a higher incidence of generating electromagnetic oversensing
Time Frame: Assessed at time of procedure
|
Assessed at time of procedure
|
Incidence of dual chamber ICDs discriminating electromagnetic oversensing.
Time Frame: At time of procedure
|
At time of procedure
|
Collaborators and Investigators
Investigators
- Principal Investigator: William T Katsyiannis, MD, Minneapolis Heart Institute
Publications and helpful links
General Publications
- Fiek M, Dorwarth U, Durchlaub I, Janko S, Von Bary C, Steinbeck G, Hoffmann E. Application of radiofrequency energy in surgical and interventional procedures: are there interactions with ICDs? Pacing Clin Electrophysiol. 2004 Mar;27(3):293-8. doi: 10.1111/j.1540-8159.2004.00430.x.
- Hauser RG, Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm. 2004 Oct;1(4):399-405. doi: 10.1016/j.hrthm.2004.05.006.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EP001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implantable Cardioverter-Defibrillators
-
CMC Ambroise ParéCompletedImplantable Cardioverter-DefibrillatorsFrance
-
M.D. Anderson Cancer CenterMike Hogg FoundationCompletedImplantable Cardioverter-Defibrillators | PacemakerUnited States
-
Emory UniversityCompletedImplantable Cardioverter-defibrillators (ICDs)United States
-
University of PennsylvaniaActive, not recruitingPacemaker | Implantable Cardioverter DefibrillatorsUnited States
-
Boston Scientific CorporationCompletedImplantable Cardioverter Defibrillators | CRT-D Cardiac Resynchronization Therapy DefibrillatorKorea, Republic of, United States, United Kingdom, Japan, Germany, Canada, Spain, Switzerland
-
Tilburg UniversityErasmus Medical Center; Catharina Ziekenhuis Eindhoven; Onze Lieve Vrouwe Gasthuis and other collaboratorsUnknownHeart Diseases | Implantable Cardioverter-DefibrillatorsNetherlands
-
Ege UniversityCompletedOutpatients | Defibrillators, ImplantableTurkey
-
University of California, San FranciscoCompletedDefibrillators, ImplantableUnited States
-
Paris Cardiovascular Research Center (Inserm U970)Hôpital Necker-Enfants MaladesCompletedImplantable Defibrillator User | Implantable Cardioverter Defibrillator Complications
-
University of AarhusUnknownDefibrillators, Implantable | PacemakerDenmark